Familial hypercholesterolemia

Molecular Genetics and Metabolism

Volumn 86, Issue 4, 2005, Pages 423-426

  Ueda, Masako ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; BILE ACID SEQUESTRANT; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN;

APHERESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; ENERGY METABOLISM; EXON; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; HUMAN; LIFESTYLE; LIPOPROTEIN METABOLISM; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVIEW; SMOKING;

HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPOPROTEINS; MUTATION; RECEPTORS, LDL;

EID: 29144484621     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2005.11.003     Document Type: Review

References (15)

1. J.L. Goldstein, H.H. Hobbs, M.S. Brown, Familial hypercholesterolemia. in: C.R. Scriver, A.L. Beaudet, D. Valle, W.S. Sly (Eds.), The Metabolic and Molecular Bases of Inherited Disease, eighth ed. McGraw-Hill, New York, 2001, pp. 2863-2913.
2. K.N. Maxwell, E.A. Fisher, J.L. Breslow, Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulumcompartment, Proc. Natl.Acad. Sci.102 (6) (2005) 2069-2074.
3. P. Michaely, W.P. Li, R.G.W. Anderson, J.C. Cohen, H.H. Hobbs, The modular adaptor protein ARH is required for low density lipoprotein (LDL) binding and internalization but not for LDL receptor clustering in coated pits, J. Biol. Chem. 279 (32) (2004) 34023-34031.
4. D. Ga.ney, L. Forster, M.J. Caslake, D. Bedford, J.P. Stewart, G. Stewart, G. Wieringa, M. Dominiczak, J.P. Miller, C.J. Packard, Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia, Atherosclerosis 162 (1) (2002) 33-43.
5. J. Genest, Lipoprotein disorders and cardiovascular risk, J. Inherit. Metabolic Dis. 26 (2003) 267-287.
6. M.S. Brown, J.L. Goldstein, A receptor-mediated pathway for cholesterol homeostasis, Science 232 (1986) 34-47.
7. D.W. Russell, M.A. Lehrman, T.C. Sudhof, T. Yamamoto, C.G. Davis, H.H. Hobbs, M.S. Brown, J.L. Goldstein, The LDL receptor in familial hypercholesterolemia: use of human mutations to dissect a membrane protein, Cold Spring Harbor Symp. Quant. Biol. 51 (1986) 81-819.
8. M.A. Austin, C.M. Hutter, R.L. Zimmern, S.E. Humphries, Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review, Am. J. Epidemiol. 160 (2004) 407-420.
9. K.E. Heath, M. Gahan, R.A. Whittall et al., Low-density lipoprotein receptor gene (LDLR) world-wide website in familial hypercholesterolemia: update, new features and mutation analysis, Atherosclerosis 154 (2001) 243-246.
10. V. Gudnason, I.N. Day, S.E Humphries, Effect on plasma lipid levels of different classes of mutations in the low-density lipoprotein receptor gene in patients with familial hypercholesterolemia, Arterioscler. Thromb. 14 (1994) 1717-1722.
11. Available from: 〈http: www.medped.org/who〉.
12. D. Marks, M. Thorogood, A.W.N. Neil, S.E. Humphries, A review on the diagnosis, natural history, and treatment of familial hypercholesterolemia, Atherosclerosis 168 (2003) 1-14.
13. P.Y. Muller, A.R. Miserez, Large heterogeneity of mutations in the gene encoding the low-density lipoprotein receptor in subjects with familial hypercholesterolemia, Athero. Suppl. 5 (2004) 1-5.
14. F. Civeira, Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 173 (2004) 55-68.
15. R.P. Naoumova, G.R. Thompson, A.K. Soutar, Current management of severe homozygous hypercholesterolaemias, Curr. Opin. Lipidol. 15 (2004) 413-422.